# Virax Biolabs Group Limited (VRAX)

> Healthcare · GB · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/VRAX/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 14.0K | $ -7.36M | $ -7.94M | $ 414.4K | $ 7.58M |
| 2025 | $ 6.5K | $ -6.21M | $ -5.29M | $ 377.0K | $ 5.70M |
| 2024 | $ 164.4K | $ -7.08M | $ -7.79M | $ 224.3K | $ 5.37M |
| 2023 | $ 9.3K | $ -5.90M | $ -4.71M | $ 146.3K | $ 9.13M |
| 2022 | $ -103.7K | $ -1.91M | $ -903.8K | $ 3.8K | $ -974.6K |
| 2021 | $ 147.2K | $ -773.8K | $ -701.5K | $ 179.5K | $ -596.2K |
| 2020 | $ 127.2K | $ -1.02M | $ -237.1K | $ 0 | $ -303.8K |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.05 |
| Liabilities / Eq | 0.13 |
| Current Ratio | 9.97 |

## Other views

- [Metrics](https://sponda.capital/en/VRAX.md)
- [Charts](https://sponda.capital/en/VRAX/charts.md)
- [Compare](https://sponda.capital/en/VRAX/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-29.